{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:07Z","timestamp":1791489667003,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":230,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101397","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:37:36Z","timestamp":1787848656000},"page":"101397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7696-4437","authenticated-orcid":false,"given":"Mingfei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsewang","family":"Tashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-4151","authenticated-orcid":false,"given":"Anthony M.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1881-3670","authenticated-orcid":false,"given":"Ghaith","family":"Abu-Zeinah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0552-161X","authenticated-orcid":false,"given":"Joel","family":"Reisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7610-084X","authenticated-orcid":false,"given":"Albert","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7463-3295","authenticated-orcid":false,"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ctarc.2026.101397_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11864-018-0529-x","article-title":"Polycythemia Vera","volume":"19","author":"Spivak","year":"2018","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101397_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.2024.20377","article-title":"Diagnosis and treatment of Polycythemia Vera: a review","volume":"333","author":"Tremblay","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101397_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clml.2019.11.010","article-title":"Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: a real-world analysis of Veterans Health Administration data","volume":"20","author":"Parasuraman","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101397_bib0004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101397_bib0005","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/ajh.27002","article-title":"Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101397_bib0006","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/bjh.19337","article-title":"Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera\u2014A matched nationwide population-based study","volume":"204","author":"Enblom-Larsson","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101397_bib0007","first-page":"848","article-title":"New guidelines from the NCCN for polycythemia vera","volume":"15","author":"Mesa","year":"2017","journal-title":"Clin Adv Hematol Oncol"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101397_bib0008","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/S2352-3026(22)00046-1","article-title":"Appropriate management of polycythaemia vera with cytoreductive drug therapy: european LeukemiaNet 2021 recommendations","volume":"9","author":"Marchetti","year":"2022","journal-title":"The Lancet Haematology"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101397_bib0009","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41408-024-01169-6","article-title":"Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors","volume":"14","author":"Barbui","year":"2024","journal-title":"Blood Cancer J"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101397_bib0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.clml.2018.08.009","article-title":"Clinical and disease characteristics from REVEAL at time of enrollment (Baseline): prospective observational study of patients with polycythemia Vera in the United States","volume":"18","author":"Grunwald","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101397_bib0011","first-page":"347","article-title":"Prevalence, incidence, and thromboembolic events in polycythemia vera: a study based on longitudinal German health claims data","volume":"104","author":"Manz","year":"2025","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101397_bib0012","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00277-019-03625-x","article-title":"Thromboembolic events in polycythemia vera","volume":"98","author":"Griesshammer","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ctarc.2026.101397_bib0013","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood-2020-137144","article-title":"Mortality and causes of death of patients with polycythemia Vera: analysis of the reveal prospective, observational study","volume":"136","author":"Stein","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101397_bib0014","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ajh.27438","article-title":"Risk of myeloproliferative neoplasms among U.S. Veterans from Korean, Vietnam, and Persian Gulf War eras","volume":"99","author":"Tiu","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101397_bib0015","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s12885-018-4422-6","article-title":"Cytoreductive treatment patterns among US veterans with polycythemia vera","volume":"18","author":"Parasuraman","year":"2018","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101397_bib0016","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101397_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70106","article-title":"Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: insights from the Landmark 2.0 global health survey","volume":"9","author":"Harrison","year":"2025","journal-title":"HemaSphere"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101397_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2025.100167","article-title":"Real-world analysis of polycythemia vera treatment reveals nonadherence to NCCN guidelines in a large proportion of patients","volume":"2","author":"Abu-Zeinah","year":"2025","journal-title":"Blood Neoplasia"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226003084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:45:46Z","timestamp":1791488746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226003084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"alternative-id":["S2468294226003084"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101397","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of polycythemia vera to reduce thrombotic events and mortality with phlebotomy and cytoreductive therapy in veterans affairs healthcare system","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101397"}}